Thermal hyperalgesia and mechanical allodynia produced by intrathecal administration of the human immunodeficiency virus-1 (HIV-1) envelope glycoprotein, gp120

Brain Research

Volumn 861, Issue 1, 2000, Pages 105-116

  Milligan, Erin D ^a   Mehmert, Kristin K ^a   Hinde, Justin L ^a   Harvey Jr , Lewis O ^a   Martin, David ^b   Tracey, Kevin J ^c   Maier, Steven F ^a   Watkins, Linda R ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b AMGEN INC   (United States)

^c PICOWER INST FOR MEDICAL RESEARCH   (United States)

Author keywords

Astrocyte; CNI 1493; Fluorocitrate; Hargreaves test; Microglia; p38 MAP kinase inhibitor; Rat; Spinal cord; Tail flick test; Touch evoked agitation test; Von Frey test

Indexed keywords

FLUOROCITRIC ACID; GLYCOPROTEIN GP 120; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; SEMAPIMOD; SYNAPTOPHYSIN; VIRUS ENVELOPE PROTEIN;

AGITATION; ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CONTROLLED STUDY; HUMAN IMMUNODEFICIENCY VIRUS 1; HYPERALGESIA; INFLAMMATION; MALE; MICROGLIA; NONHUMAN; PAIN; PAIN THRESHOLD; PRIORITY JOURNAL; RAT; TAIL FLICK TEST;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CITRATES; HEAT; HIV ENVELOPE PROTEIN GP120; HYDRAZONES; HYPERALGESIA; MALE; NEUROGLIA; RATS; RATS, SPRAGUE-DAWLEY; SPECIFIC PATHOGEN-FREE ORGANISMS; SPINAL CORD; TOUCH;

EID: 0034615875     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(00)02050-3     Document Type: Article

References (64)

1. Bajetto A., Bonavia R., Barbero S., Florio T., Costa A., Schettini G. Expression of chemokine receptors in the rat brain. Ann. N.Y. Acad. Sci. 876:1999;201-209.
2. Baldassare J.J., Bi Y., Bellone C.J. The role of p38 mitogen-activated protein kinase in IL-1 beta transcription. J. Immunol. 162:1999;5367-5373.
3. Balis F.M., Pizzo P.A., Murphy R.F., Eddy J., Jarosinki P.F. The pharmacokinetics of zidovudine administered by continuous infusion in children. Ann. Intern. Med. 110:1989;279-285.
4. Berg-Johnsen J., Paulsen R.E., Fonnum F., Langmoen I.A. Changes in evoked potentials and amino acid content during fluorocitrate action studied in rat hippocampal cortex. Exp. Brain Res. 96:1993;241-246.
5. Bhat N.R., Zhang P., Lee J.C., Hogan E.L. Extracellular signal-regulated kinase and p38 subgroups of mitogen-activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor-alpha gene expression in endotoxin-stimulated primary glial cultures. J. Neurosci. 18:1998;1633-1641.
6. Bianchi M., Bloom O., Raabe T., Cohen P.S., Chesney J., Sherry B., Schmidtmayerova H., Calandra T., Zhang X., Bukrinsky M., Ulrich P., Cerami A., Tracey K.J. Suppression of proinflammatory cytokines in monocytes by a tetravalent guanylhydrazone. J. Exp. Med. 183:1996;927-936.
7. Bianchi M., Ulrich P., Bloom O., Meistrell M., Zimmerman G.A., Schmidtmayerova H., Bukrinsky M., Donnelley T., Bucala R., Sherry B., Manogue K.R., Tortolani A.J., Cerami A., Tracey K.J. An inhibitor of macrophage arginine transport and nitric oxide production (CNI-1493) prevents acute inflammation and endotoxin lethality. Mol. Med. 1:1995;254-266.
8. Bjork L., Tracey K.J., Ulrich P., Bianchi M., Cohen P.S., Akerlund K., Fehniger T.E., Andersson U., Andersson J. Targeted suppression of cytokine production in monocytes but not in T lymphocytes by a tetravalent guanylhydrazone (CNI-1493). J. Infect. Dis. 176:1997;1303-1312.
9. Breitbart W., McDonald M.V., Rosenfeld B., Passik S.D., Hewitt D., Thaler H., Portenoy R.K. Pain in ambulatory AIDS patients: pain characteristics and medical correlates. Pain. 68:1996;315-321.
10. Chaplan S.R., Bach F.W., Pogrel J.W., Chung J.M., Yaksh T.L. Quantitative assessment of tactile allodynia in the rat paw. J. Neurosci. Methods. 53:1994;55-63.
11. D'Amour G.E., Smith D.L. A method for determining loss of pain sensation. J. Pharmacol. Exp. Ther. 72:1941;74-79.
12. DaSilva J., Pierrat B., Mary J.L., Lesslauer W. Blockade of p38 mitogen-activated protein kinase pathway inhibits inducible nitric-oxide synthase expression in mouse astrocytes. J. Biol. Chem. 272:1997;28373-28380.
13. DeLeo J.A., Colburn R.W., Nichols M., Malhotra A. Interleukin-6-mediated hyperalgesia/allodynia and increased spinal IL-6 expression in a rat mononeuropathy model. J. Interferon Cytokine Res. 16:1996;695-700.
14. Diederich N., Ackermann R., Jurgens R., Ortseifen M., Thun F., Schneider M., Vukadinovic I. Early involvement of the nervous system by human immune deficiency virus (HIV). A study of 79 patients. Eur. Neurol. 28:1988;93-103.
15. Dixon W. Efficient analysis of experimental observations. Ann. Rev. Pharmacol. Toxicol. 20:1980;441-462.
16. G. Dutton, Astrocyte Amino Acids: Evidence for Release and Possible Interactions with Neurons, Academic Press, San Diego, 1993, pp. 173-192.
17. Gitter B.D., Regoli D., Howbert J.J., Glasebrook A.L., Waters D.C. Interleukin-6 secretion from human astrocytoma cells induced by substance P. J. Neuroimmunol. 51:1994;101-108.
18. Giulian D., Wendt E., Vaca K., Noonan C.A. The envelope glycoprotein of human immunodeficiency virus type 1 stimulates release of neurotoxins from monocytes. Proc. Natl. Acad. Sci. 90:1993;2769-2773.
19. Harada J., Sugimoto M. An inhibitor of p38 and JNK MAP kinases prevents activation of caspase and apoptosis of cultured cerebellar granule neurons. Japan. J. Pharmacol. 79:1999;369-378.
20. Hargreaves K., Dubner R., Brown F., Flores C., Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain. 32:1988;77-88.
21. Hartman N.R., Yarchoan R., Pluda J.M., Thomas R.V., Marczyk K.S., Broder S., Johns D.G. Pharmacokinetics of 2′,3′-dideoxyadenosine and 2′,3′-dideoxyinosine in patients with severe human immunodeficiency virus infection. Clin. Pharmacol. Ther. 47:1990;647-654.
22. Hartung H., Heininger K., Schafer B., Tokya K. Substance P and astrocytes: stimulation of the cyclooxygenase pathway of arachidonic acid metabolism. FASEB J. 2:1988;48-51.
23. Harvey L.O. Efficient estimation of sensory thresholds. Behav. Res. Meth. Instrum. Comput. 18:1986;623-632.
24. Hassel B., Paulsen R.E., Johnson A., Fonnum F. Selective inhibition of glial cell metabolism by fluorocitrate. Brain Res. 576:1992;120-124.
25. Heidenreich K.A., Kummer J.L. Inhibition of p38 mitogen-activated protein kinase by insulin in cultured fetal neurons. J. Biol. Chem. 271:1996;9891-9894.
26. Hesselgesser J., Taub D., Baskar P., Greenberg M., Hoxie J., Kolson D.L., Koruk R. Neuronal apoptosis induced by HIV-1 gp120 and the chemokine SDF-1 alpha is mediated by the chemokine receptor CXCR4. Curr. Biol. 8:1998;595-598.
27. Hewitt D.J., McDonald M., Pertenoy R.K., Rosenfeld B., Passik S., Breitbart W. Pain syndromes and etiologies in ambulatory AIDS patients. Pain. 70:1997;117-123.
28. Kaul M., Lipton S.A. Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis. Proc. Natl. Acad. Sci. 96:1999;8212-8216.
29. Kauppila T., Kontinen V., Pertovaara A. Weight bearing of the limb as a confounding factor in assessment of mechanical allodynia in the rat. Pain. 74:1998;55-59.
30. Klein R.S., Williams K.C., Alvarez-Hernandez X., Westmoreland S., Force T., Lackner A.A., Luster A.D. Chemokine receptor expression and signaling in macaque and human fetal neurons and astrocytes: implications for the neuropathogenesis of AIDS. J. Immunol. 163:1999;1636-1646.
31. Koka P., He K., Zack J.A., Kitchen S., Peacock W., Fried I., Tran T., Yashar S.S., Merrill J.E. Human immunodeficiency virus 1 envelope proteins induce interleukin 1, tumor necrosis factor alpha, and nitric oxide in glial cultures derived from fetal, neonatal and adult human brain. J. Exp. Med. 182:1995;941-951.
32. Kong L.Y., Wilson B.C., McMillian M.K., Bing G., Hudson P.M., Hong J.S. The effects of the HIV-1 envelope protein gp120 on the production of nitric oxide and proinflammatory cytokines in mixed glial cultures. Cell Immunol. 172:1996;77-83.
33. Kreutzberg G.W. Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 19:1996;312-318.
34. Kure K., Llena J.F., Lyman W.D., Soeiro R., Weidenheim K.M., Hirano A., Dickson D.W. Human immunodeficiency virus-1 infection of the nervous system: an autopsy study of 268 adult, pediatric, and fetal brains. Human Pathol. 22:1991;700-710.
35. Largo C., Cuevas P., Somjen G.G., Martin del Rio R., Herrera O. The effect of depression glial function in rat brain in situ on ion homeostasis, synaptic transmission, and neuron survival. J. Neurosci. 16:1996;1219-1229.
36. Largo C., Ibarz J.M., Herreras O. Effects of the gliotoxin fluorocitrate on spreading depression and glial membrane potential in rat brain in situ. J. Neurophysiol. 78:1997;295-307.
37. Lipton S.A., Yeh M., Dreyer E.B. Update on current models of HIV-related neuronal injury: platelet-activating factor, arachidonic acid and nitric oxide. Adv. Neuroimmunol. 4:1994;181-188.
38. Madani N., Kozak S.L., Kavanaugh M.P., Kabat D. gp120 envelope glycoproteins of human immunodeficiency viruses competitively antagonize signaling by coreceptors CXCR4 and CCR5. Proc. Natl. Acad. Sci. 95:1998;8005-8010.
39. Marriott D., Wilkin G.P., Coote P.R., Wood J.N. Eicosanoid synthesis by spinal cord astrocytes is evoked by substance P; possible implication for nociception and pain. Adv. Prostaglandin, Thromboxane, Leukotriene Res. 21B:1991;739-741.
40. Meller S.T., Cummings C.P., Traub R.J., Gebhart G.F. The role of nitric oxide in the development and maintenance of the hyperalgesia produced by intraplantar injection of carageenan in the rat. Neuroscience. 60:1994;367-374.
41. Meller S.T., Dykstra C., Grzbycki D., Murphy S., Gebhart G.F. The possible role of glia in nociceptive processing and hyperalgesia in the spinal cord of the rat. Neuropharmacology. 33:1994;1471-1478.
42. Meucci O., Miller R.J. gp120-induced neurotoxicity in hippocampal pyramidal neuron cultures: protective action of TFG-beta1. J. Neurosci. 16:1996;4080-4088.
43. Milligan E.D., Hinde J.L., Mehmert K., Maier S.F., Watkins L.R. A method for increasing the viability of the external portion of lumbar catheters placed in the spinal subarachnoid space of rats. J. Neurosci. Methods. 90:1999;81-86.
44. S. Murphy (Ed.), Astrocytes: Pharmacology and Function, Academic Press, San Diego, 1993.
45. Pattarini R., Pittaluga A., Raiteri M. The humanimmunodeficiency virus-1 envelope protein gp120 binds through its V3 sequence to the glycine site of N-methyl-D-aspartate receptors mediating noradrenaline release in the hippocampus. Neuroscience. 87:1998;147-157.
46. Paulsen R.E., Contestabile A., Villani L., Fonnum F. An in vivo model for studying function of brain tissue temporarily devoid of glial cell metabolism: the use of fluorocitrate. J. Neurochem. 48:1987;1377-1385.
47. Perregaux D.G., Dean D., Cronan M., Connelly P., Gabel C.A. Inhibition of interleukin-1 beta production by SKF86002: evidence of two sites of in vitro activity and of a time and system dependence. Mol. Pharmacol. 48:1995;433-442.
48. Schneider-Schaulies J., Schneider-Schaulies S., Brinkmann R., Tas P., Halbrugge M., Walter U., Homes H.C., TerMeurlen V. HIV-1 gp120 receptor on CD4-negative brain cells activates a tyrosine kinase. Virology. 191:1992;765-772.
49. Schumann R.R., Pfeil D., Freyer D., Buerger W., Lamping N., Kirschning C.J., Goebel U.B., Weber J.R. Lipopolysaccharide and pneumococcal cell wall components activate the mitogen activated protein kinases (MAPK) erk-1, erk-2, and p38 in astrocytes. Glia. 22:1998;295-305.
50. Slart R., Yu A.L., Yaksh T.L., Sorkin L.R. An animal model of pain produced by systemic administration of an immunotherapeutic anti-ganglioside antibody. Pain. 69:1997;119-125.
51. Sundar S.K., Cierpial M.A., Kamaraju L.S., Long S., Hsieh S., Lorenz C., Aaron M., Ritchie J.C., Weiss J.M. Human immunodeficiency virus glycoprotein (gp120) infused into rat brain induces interleukin 1 to elevate pituitary-adrenal activity and decrease peripheral cellular immune responses. Proc. Natl. Acad. Sci. 88:1991;11246-11250.
52. Thuluvath P.J., Connolly G.M., Forbes A., Gazzard B.G. Abdominal pain in HIV infection. Q. J. Med. 78:1991;275-285.
53. Treutwein B., Strasburger H. Fitting the psychometric function. Percept. Psychophys. 61:1999;87-106.
54. Tyor W.R., Glas J.D., Griffin J., Becker P.S., McArther J.C., Bezman L., Griffin D.E. Cytokine expression in the brain during the acquired immunodeficiency syndrome. Ann. Neurol. 31:1992;349-360.
55. Ushijima H., Nishio O., Klocking R., Perovic S., Muller W.E.G. Exposure to gp120 of HIV-1 induces an increased release of arachidonic acid in rat primary neuronal cell culture followed by NMDA receptor-mediated neurotoxicity. Eur. J. Neurosci. 7:1995;1353-1359.
56. VanLeeuwen R., Katlama C., Kitchen V., Boucher C.A., Tubiana R., McBride M., Ingrand D., Weber J., Hill A., McDade H. Evaluation of safety and efficacy of 3TC (lamivudine) in patients with asymptomatic or mildly symptomatic human immunodeficiency virus infection: a phase I/II study. J. Infect. Dis. 171:1996;1166-1171.
57. Vesce S., Bezzi P., Rossi D., Meldolesi J., Volterra A. HIV-1 gp120 glycoprotein affects the astrocyte control of extracellular glutamate by both inhibiting the uptake and stimulating the release of the amino acid. FEBS Lett. 411:1997;107-109.
58. Watkins L.R., Deak T., Silbert L., Martinez J., Goehler L., Relton J., Martin D., Maier S.F. Evidence for involvement of spinal cord glia in diverse models of hyperalgesia. Proc. Soc. Neurosci. 21:1995;879.
59. Watkins L.R., Maier S.F. Implications of immune-to-brain communication for sickness and pain. Proc. Natl. Acad. Sci. 96:1999;7710-7713.
60. Watkins L.R., Maier S.F., Goehler L.E. Basic science review: immune activation: the role of proinflammatory cytokines in inflammation, illness responses, and pathological pain states. Pain. 63:1995;289-302.
61. Watkins L.R., Martin D., Ulrich P., Tracey K.J., Maier S.F. Evidence for involvement of spinal cord glia in subcutaneous formalin induced hyperalgesia in the rat. Pain. 71:1997;225-235.
62. Westmoreland S.V., Rottman J.B., Williams K.C., Lackner A.A., Sasseville V.G. Chemokine receptor expression on resident and inflammatory cells in the brain of macaques with simian immunodeficiency virus encephalitus. Am. J. Pathol. 152:1998;659-665.
63. W.D.J. Willis, Hyperalgesia and Allodynia, Raven Press, New York, 1992.
64. Zheng J., Thylin M.R., Ghorpade A., Xiong H., Persidsky Y., Cotter R., Niemann D., Che M., Zeng Y.C., Gelbard H.A., Shepard R.B., Swartz J.M., Gendelman H.E. Intracellular CXCR4 signaling, neuronal apoptosis and neuropathogenic mechanisms of HIV-1-associated dementia. J. Neuroimmunol. 98:1999;185-200.